Access to Medicines

MSF: Global vaccines community must urgently support roll out of new more affordable pneumonia vaccine

by

Global vaccines community must do everything it can to help introduce the new, more affordable pneumonia vaccine in all countries, especially middle-income countries Barcelona – As governments and the global vaccines community gather this week at the first ever Global Forum on Childhood Pneumonia in Barcelona, Doctors Without Borders/Médecins Sans Frontières (MSF) urges Gavi, the … Read more

Access to medicines: As J&J release earnings, MSF protests price of lifesaving TB drug

by

As J&J release earnings, MSF protests price of lifesaving TB drug in front of New York Stock Exchange New York, 22 January 2020—Médecins Sans Frontières (MSF) protested in front of the New York Stock Exchange in New York today, demanding the pharmaceutical corporation Johnson & Johnson (J&J) make the tuberculosis (TB) drug bedaquiline available for … Read more

Access to medicines: Gavi must ensure more children get new, more affordable pneumonia vaccine

by

Geneva, 21 January 2020 — As Gavi, the Vaccine Alliance, starts to commemorate its 20th year and launches a new fundraising appeal, the international medical humanitarian organisation Doctors Without Borders/Médecins Sans Frontières (MSF) stressed that more must be done to make sure the 55 million children who do not have access to the pneumonia vaccine … Read more

MSF and TB activists disrupt opening of TB conference to protest drug corporations keeping life-saving medicines from people

by

Newer medicines for DR-TB are desperately needed, but barriers to access, including high prices, keep them out of reach for most people around the world. Hyderabad, 30 October – Doctors Without Borders/Médecins Sans Frontières (MSF) joined tuberculosis (TB) activists to disrupt the opening ceremony of the 50th Union World Conference on Lung Health in Hyderabad today, … Read more

Access to medicines: MSF demands Johnson & Johnson reduce price of lifesaving TB drug

by

GENEVA – Doctors Without Borders/Médecins Sans Frontières (MSF) has launched a global campaign calling on pharmaceutical corporation Johnson & Johnson (J&J) to lower the price of its anti-tuberculosis medicine bedaquiline to no more than US$1 per day for people everywhere who need it, in order to allow scale-up of drug-resistant tuberculosis (DR-TB) treatment and reduce deaths.   … Read more

MSF urges PM Modi not to make any trade commitments to US threatening access to medicines

by

Ahead of the Prime Minister Narendra Modi’s visit to the US to discuss a ‘trade-package’ with the US President Donald Trump, Médecins Sans Frontières/ Doctors Without Borders (MSF) urges the Indian government to not make any commitments regarding intellectual property, as it will impact millions of people who rely on affordable generic medicines produced in … Read more

Gilead Sciences fails on promise to expand access to lifesaving drug for people living with HIV

by

Inaction by US pharmaceutical corporation Gilead to follow through on its so-called ‘access initiative’ leaves people unable to access a vital drug to treat a deadly infection. Delhi/Geneva – Pharmaceutical corporation Gilead Sciences has failed to deliver on promises to make an important drug available to people suffering from a life-threatening HIV-related infection, the medical humanitarian … Read more

MSF: U.S. Special 301 report undermines efforts to lower medicine prices globally

by

On the eve of World Intellectual Property Day, the United States Trade Representative released its annual “Special 301 Report.” Developing countries like India and Malaysia once again face unfair pressure from the US government over the measures these countries have taken to try to protect access to medicines. The Special 301 report is an annual … Read more

Tuberculosis: TB activists challenge Johnson & Johnson patent application on bedaquiline in India

by

Mumbai/Cape Town – Doctors Without Borders/Médecins Sans Frontières (MSF) is supporting a patent challenge filed in India this week by two tuberculosis survivors, to prevent pharmaceutical corporation Johnson & Johnson (J&J) from extending its monopoly on the tuberculosis drug bedaquiline. Nandita Venkatesan from Mumbai, India and Phumeza Tisile from Khayelitsha, South Africa, who filed the patent … Read more

Tuberculosis: TB activists challenge Johnson & Johnson patent application on bedaquiline in India

by

Mumbai/Cape Town – Doctors Without Borders/Médecins Sans Frontières (MSF) is supporting a patent challenge filed in India this week by two tuberculosis survivors, to prevent pharmaceutical corporation Johnson & Johnson (J&J) from extending its monopoly on the tuberculosis drug bedaquiline. Nandita Venkatesan from Mumbai, India and Phumeza Tisile from Khayelitsha, South Africa, who filed the … Read more